Distant-relapse analysis of STAR-01, a randomized phase III trial comparing preoperative chemoradiation with or without oxaliplatin in locally adva...

Date 29 June 2016
Event ESMO World Congress on Gastrointestinal Cancer 2016
Session ESMO World Congress on Gastrointestinal Cancer 2016 - Abstracts book
Presenter S. Lonardi
Citation Annals of Oncology (2016) 27 (2): 118-128. 10.1093/annonc/mdw198
Authors S. Lonardi1, L. Cionini2, C. Pinto3, S. Cordio4, G. Rosati5, A. Sartore Bianchi6, A. Tagliagambe7, M. Frisinghelli8, V. Zagonel1, P. Rosetti9, M.E. Negru10, A. Bonetti11, M.C. Tronconi12, G. Luppi13, A.R. Marsella14, C. Corsi15, A.M. Bochicchio16, G. Aprile17, R. Niespolo18, C. Granetto19, L. Boni20, C. Aschele21
  • 1Oncologia Medica 1, Istituto Oncologico Veneto - IRCCS, Padova, Italy, /
  • 2Centro Oncologico Fiorentino, Sesto Fiorentino, Italy, /
  • 3Arcispedale Santa Maria Nuova, Reggio Emilia, Italy, /
  • 4Department of Oncology, Garibaldi Nesima Hospital, Catania, Italy, /
  • 5Medical Oncology, San Carlo Hospital, Potenza, Italy, /
  • 6Dipartimento Oncologico, Ospedale Niguarda Ca' Granda, Milano, Italy, /
  • 7Civico Ospedale di Carrara (ASL 1), Carrara, Italy, /
  • 8Oncology Department S. Chiara Hospital, Trento, Italy, /
  • 9IRST - IRCCS, Forlì, Italy, /
  • 10Azienda Ospedaliero - Universitaria, Novara, Italy, /
  • 11U.O. Oncologia, Ospedale Mater Salutis, Legnago, Italy, /
  • 12Humanitas Cancer Center, Istituto Clinico Humanitas IRCCS, Rozzano, Italy, /
  • 13Azienda Ospedaliero-Universitaria, Modena, Italy, /
  • 14ASL DI TARANTO, Taranto, Italy, /
  • 15Ospedale San Giovanni Calibita, Grottaferrata, Italy, /
  • 16CROB IRCCS, Rionero, Vulture, Italy, /
  • 17Department of Oncology, University and General Hospital, Udine, Italy, /
  • 18H.S. S. Gerardo, Monza, Italy, /
  • 19U.O. Oncologia Medica, Azienda Sanitaria Ospedaliera S. Croce e Carle, Cuneo, Italy, /
  • 20Clinical Trials Coordinating Center, Istituto Toscano Tumori, Firenze, Italy, /
  • 21ASL 5 La Spezia, La Spezia, Italy, /

Abstract

STAR-01 is a randomized phase III trial investigating the effect of adding oxaliplatin (OXA) to preoperative (preop) 5-fluorouracil (FU)-based pelvic chemoradiation (CRT) in patients (pts) with resectable locally advanced rectal cancer (LARC).